CD44 and lung carcinoma: These biomimetic nanocarriers, which mimic the lipid make-up and surface properties of the cell membrane of lung cancer, have been shown to have enhanced cellular affinity for CD44 cancer-overexpressing cells, leading to better uptake and immune activation (114).